SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030130
Filing Date
2019-08-07
Accepted
2019-08-07 16:32:51
Documents
50
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 Q2 2019 10-Q snss-10q_20190630.htm 10-Q 1324761
2 EX-31.1 snss-ex311_6.htm EX-31.1 16675
3 EX-31.2 snss-ex312_7.htm EX-31.2 16849
4 EX-32.1 snss-ex321_8.htm EX-32.1 9349
5 GRAPHIC ghxa003qubzu000001.jpg GRAPHIC 3336
  Complete submission text file 0001564590-19-030130.txt   4031329

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snss-20190630.xml EX-101.INS 642716
7 XBRL TAXONOMY EXTENSION SCHEMA snss-20190630.xsd EX-101.SCH 38000
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snss-20190630_cal.xml EX-101.CAL 42183
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snss-20190630_def.xml EX-101.DEF 121789
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE snss-20190630_lab.xml EX-101.LAB 294152
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snss-20190630_pre.xml EX-101.PRE 214698
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51531 | Film No.: 191005942
SIC: 2834 Pharmaceutical Preparations